nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCB11—Ethinyl Estradiol—osteoporosis	0.225	0.296	CbGbCtD
Fluorescein—ABCC1—Zoledronate—osteoporosis	0.211	0.278	CbGbCtD
Fluorescein—ABCC1—Conjugated Estrogens—osteoporosis	0.117	0.155	CbGbCtD
Fluorescein—CYP1A1—Cholecalciferol—osteoporosis	0.079	0.104	CbGbCtD
Fluorescein—CYP1A1—Estradiol—osteoporosis	0.0636	0.0838	CbGbCtD
Fluorescein—SLC22A6—Conjugated Estrogens—osteoporosis	0.0636	0.0837	CbGbCtD
Fluorescein—ABCB11—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00557	0.243	CbGpPWpGaD
Fluorescein—ABCB11—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—CYP27A1—osteoporosis	0.00147	0.0642	CbGpPWpGaD
Fluorescein—ABCB11—Synthesis of bile acids and bile salts—CYP27A1—osteoporosis	0.00134	0.0584	CbGpPWpGaD
Fluorescein—ABCB11—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00106	0.0464	CbGpPWpGaD
Fluorescein—ABCB11—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000891	0.0388	CbGpPWpGaD
Fluorescein—ABCB11—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000666	0.029	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000512	0.0223	CbGpPWpGaD
Fluorescein—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000417	0.00192	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000417	0.00191	CcSEcCtD
Fluorescein—Hypertension—Risedronate—osteoporosis	0.000416	0.00191	CcSEcCtD
Fluorescein—Discomfort—Ethinyl Estradiol—osteoporosis	0.000416	0.00191	CcSEcCtD
Fluorescein—Malaise—Pamidronate—osteoporosis	0.000413	0.0019	CcSEcCtD
Fluorescein—Pain—Raloxifene—osteoporosis	0.000413	0.0019	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000412	0.00189	CcSEcCtD
Fluorescein—Syncope—Pamidronate—osteoporosis	0.000411	0.00189	CcSEcCtD
Fluorescein—Chest pain—Risedronate—osteoporosis	0.000411	0.00189	CcSEcCtD
Fluorescein—Dysgeusia—Zoledronate—osteoporosis	0.00041	0.00188	CcSEcCtD
Fluorescein—Pain—Ibandronate—osteoporosis	0.000408	0.00188	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000408	0.00187	CcSEcCtD
Fluorescein—Pruritus—Etidronic acid—osteoporosis	0.000407	0.00187	CcSEcCtD
Fluorescein—Gastrointestinal pain—Estropipate—osteoporosis	0.000407	0.00187	CcSEcCtD
Fluorescein—Feeling abnormal—Alendronate—osteoporosis	0.000404	0.00186	CcSEcCtD
Fluorescein—Oedema—Ethinyl Estradiol—osteoporosis	0.000404	0.00186	CcSEcCtD
Fluorescein—Erythema—Conjugated Estrogens—osteoporosis	0.000403	0.00185	CcSEcCtD
Fluorescein—Loss of consciousness—Pamidronate—osteoporosis	0.000403	0.00185	CcSEcCtD
Fluorescein—Gastrointestinal pain—Alendronate—osteoporosis	0.000401	0.00184	CcSEcCtD
Fluorescein—Cough—Pamidronate—osteoporosis	0.0004	0.00184	CcSEcCtD
Fluorescein—Pain—Calcitriol—osteoporosis	0.0004	0.00184	CcSEcCtD
Fluorescein—Convulsion—Pamidronate—osteoporosis	0.000397	0.00183	CcSEcCtD
Fluorescein—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000396	0.00182	CcSEcCtD
Fluorescein—Hypertension—Pamidronate—osteoporosis	0.000396	0.00182	CcSEcCtD
Fluorescein—Urticaria—Estropipate—osteoporosis	0.000396	0.00182	CcSEcCtD
Fluorescein—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000395	0.00181	CcSEcCtD
Fluorescein—Gastrointestinal pain—Raloxifene—osteoporosis	0.000394	0.00181	CcSEcCtD
Fluorescein—Abdominal pain—Estropipate—osteoporosis	0.000394	0.00181	CcSEcCtD
Fluorescein—Feeling abnormal—Ibandronate—osteoporosis	0.000394	0.00181	CcSEcCtD
Fluorescein—Tremor—Zoledronate—osteoporosis	0.000392	0.0018	CcSEcCtD
Fluorescein—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000392	0.0018	CcSEcCtD
Fluorescein—Gastrointestinal pain—Ibandronate—osteoporosis	0.000391	0.00179	CcSEcCtD
Fluorescein—Urticaria—Alendronate—osteoporosis	0.00039	0.00179	CcSEcCtD
Fluorescein—Ill-defined disorder—Zoledronate—osteoporosis	0.000389	0.00179	CcSEcCtD
Fluorescein—Abdominal pain—Alendronate—osteoporosis	0.000388	0.00178	CcSEcCtD
Fluorescein—Shock—Risedronate—osteoporosis	0.000387	0.00178	CcSEcCtD
Fluorescein—Nervous system disorder—Risedronate—osteoporosis	0.000386	0.00177	CcSEcCtD
Fluorescein—Discomfort—Pamidronate—osteoporosis	0.000386	0.00177	CcSEcCtD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.000384	0.0167	CbGpPWpGaD
Fluorescein—Skin disorder—Risedronate—osteoporosis	0.000382	0.00176	CcSEcCtD
Fluorescein—Gastrointestinal pain—Calcitriol—osteoporosis	0.000382	0.00176	CcSEcCtD
Fluorescein—Abdominal pain—Raloxifene—osteoporosis	0.000381	0.00175	CcSEcCtD
Fluorescein—Urticaria—Ibandronate—osteoporosis	0.000379	0.00174	CcSEcCtD
Fluorescein—Malaise—Zoledronate—osteoporosis	0.000378	0.00174	CcSEcCtD
Fluorescein—Abdominal pain—Ibandronate—osteoporosis	0.000378	0.00173	CcSEcCtD
Fluorescein—CYP1A1—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000377	0.0165	CbGpPWpGaD
Fluorescein—Syncope—Zoledronate—osteoporosis	0.000376	0.00173	CcSEcCtD
Fluorescein—Oedema—Pamidronate—osteoporosis	0.000374	0.00172	CcSEcCtD
Fluorescein—Anaphylactic shock—Pamidronate—osteoporosis	0.000374	0.00172	CcSEcCtD
Fluorescein—Urticaria—Calcitriol—osteoporosis	0.000371	0.00171	CcSEcCtD
Fluorescein—Abdominal pain—Calcitriol—osteoporosis	0.00037	0.0017	CcSEcCtD
Fluorescein—Hypoaesthesia—Estradiol—osteoporosis	0.000369	0.0017	CcSEcCtD
Fluorescein—Shock—Pamidronate—osteoporosis	0.000368	0.00169	CcSEcCtD
Fluorescein—Loss of consciousness—Zoledronate—osteoporosis	0.000368	0.00169	CcSEcCtD
Fluorescein—Hypersensitivity—Estropipate—osteoporosis	0.000367	0.00169	CcSEcCtD
Fluorescein—Nervous system disorder—Pamidronate—osteoporosis	0.000367	0.00169	CcSEcCtD
Fluorescein—Vomiting—Etidronic acid—osteoporosis	0.000366	0.00168	CcSEcCtD
Fluorescein—Cough—Zoledronate—osteoporosis	0.000365	0.00168	CcSEcCtD
Fluorescein—Tachycardia—Pamidronate—osteoporosis	0.000365	0.00168	CcSEcCtD
Fluorescein—Rash—Etidronic acid—osteoporosis	0.000363	0.00167	CcSEcCtD
Fluorescein—Convulsion—Zoledronate—osteoporosis	0.000363	0.00167	CcSEcCtD
Fluorescein—Dermatitis—Etidronic acid—osteoporosis	0.000363	0.00167	CcSEcCtD
Fluorescein—Hyperhidrosis—Pamidronate—osteoporosis	0.000362	0.00166	CcSEcCtD
Fluorescein—Syncope—Conjugated Estrogens—osteoporosis	0.000362	0.00166	CcSEcCtD
Fluorescein—Hypertension—Zoledronate—osteoporosis	0.000362	0.00166	CcSEcCtD
Fluorescein—Hypersensitivity—Alendronate—osteoporosis	0.000361	0.00166	CcSEcCtD
Fluorescein—Headache—Etidronic acid—osteoporosis	0.000361	0.00166	CcSEcCtD
Fluorescein—Asthenia—Estropipate—osteoporosis	0.000357	0.00164	CcSEcCtD
Fluorescein—Chest pain—Zoledronate—osteoporosis	0.000357	0.00164	CcSEcCtD
Fluorescein—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000354	0.00163	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000354	0.00163	CcSEcCtD
Fluorescein—Paraesthesia—Risedronate—osteoporosis	0.000353	0.00162	CcSEcCtD
Fluorescein—Pruritus—Estropipate—osteoporosis	0.000352	0.00162	CcSEcCtD
Fluorescein—Discomfort—Zoledronate—osteoporosis	0.000352	0.00162	CcSEcCtD
Fluorescein—Asthenia—Alendronate—osteoporosis	0.000352	0.00162	CcSEcCtD
Fluorescein—Hypersensitivity—Ibandronate—osteoporosis	0.000352	0.00162	CcSEcCtD
Fluorescein—Cough—Conjugated Estrogens—osteoporosis	0.000352	0.00162	CcSEcCtD
Fluorescein—Dyspnoea—Risedronate—osteoporosis	0.000351	0.00161	CcSEcCtD
Fluorescein—Hypotension—Pamidronate—osteoporosis	0.00035	0.00161	CcSEcCtD
Fluorescein—Convulsion—Conjugated Estrogens—osteoporosis	0.000349	0.00161	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000349	0.0016	CcSEcCtD
Fluorescein—Pruritus—Alendronate—osteoporosis	0.000347	0.00159	CcSEcCtD
Fluorescein—Hypersensitivity—Calcitriol—osteoporosis	0.000344	0.00158	CcSEcCtD
Fluorescein—Cardiac disorder—Estradiol—osteoporosis	0.000344	0.00158	CcSEcCtD
Fluorescein—Chest pain—Conjugated Estrogens—osteoporosis	0.000343	0.00158	CcSEcCtD
Fluorescein—Asthenia—Ibandronate—osteoporosis	0.000343	0.00157	CcSEcCtD
Fluorescein—Nausea—Etidronic acid—osteoporosis	0.000342	0.00157	CcSEcCtD
Fluorescein—Oedema—Zoledronate—osteoporosis	0.000342	0.00157	CcSEcCtD
Fluorescein—Anaphylactic shock—Zoledronate—osteoporosis	0.000342	0.00157	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000341	0.00157	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Risedronate—osteoporosis	0.00034	0.00156	CcSEcCtD
Fluorescein—Pruritus—Ibandronate—osteoporosis	0.000338	0.00155	CcSEcCtD
Fluorescein—Pain—Risedronate—osteoporosis	0.000337	0.00155	CcSEcCtD
Fluorescein—Angiopathy—Estradiol—osteoporosis	0.000336	0.00155	CcSEcCtD
Fluorescein—Shock—Zoledronate—osteoporosis	0.000336	0.00155	CcSEcCtD
Fluorescein—Paraesthesia—Pamidronate—osteoporosis	0.000336	0.00154	CcSEcCtD
Fluorescein—Asthenia—Calcitriol—osteoporosis	0.000335	0.00154	CcSEcCtD
Fluorescein—Nervous system disorder—Zoledronate—osteoporosis	0.000335	0.00154	CcSEcCtD
Fluorescein—Immune system disorder—Estradiol—osteoporosis	0.000335	0.00154	CcSEcCtD
Fluorescein—Mediastinal disorder—Estradiol—osteoporosis	0.000334	0.00154	CcSEcCtD
Fluorescein—Dyspnoea—Pamidronate—osteoporosis	0.000334	0.00153	CcSEcCtD
Fluorescein—Tachycardia—Zoledronate—osteoporosis	0.000334	0.00153	CcSEcCtD
Fluorescein—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000333	0.00153	CcSEcCtD
Fluorescein—Chills—Estradiol—osteoporosis	0.000333	0.00153	CcSEcCtD
Fluorescein—Skin disorder—Zoledronate—osteoporosis	0.000332	0.00153	CcSEcCtD
Fluorescein—Pruritus—Calcitriol—osteoporosis	0.000331	0.00152	CcSEcCtD
Fluorescein—Hyperhidrosis—Zoledronate—osteoporosis	0.00033	0.00152	CcSEcCtD
Fluorescein—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00033	0.00152	CcSEcCtD
Fluorescein—Dizziness—Estropipate—osteoporosis	0.000329	0.00151	CcSEcCtD
Fluorescein—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000329	0.00151	CcSEcCtD
Fluorescein—Oedema—Conjugated Estrogens—osteoporosis	0.000329	0.00151	CcSEcCtD
Fluorescein—Dizziness—Alendronate—osteoporosis	0.000324	0.00149	CcSEcCtD
Fluorescein—Shock—Conjugated Estrogens—osteoporosis	0.000324	0.00149	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000323	0.00148	CcSEcCtD
Fluorescein—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000323	0.00148	CcSEcCtD
Fluorescein—Erythema—Estradiol—osteoporosis	0.000323	0.00148	CcSEcCtD
Fluorescein—Gastrointestinal pain—Risedronate—osteoporosis	0.000322	0.00148	CcSEcCtD
Fluorescein—Tachycardia—Conjugated Estrogens—osteoporosis	0.000321	0.00148	CcSEcCtD
Fluorescein—Urticaria—Ethinyl Estradiol—osteoporosis	0.000321	0.00147	CcSEcCtD
Fluorescein—Pain—Pamidronate—osteoporosis	0.00032	0.00147	CcSEcCtD
Fluorescein—Skin disorder—Conjugated Estrogens—osteoporosis	0.00032	0.00147	CcSEcCtD
Fluorescein—Hypotension—Zoledronate—osteoporosis	0.000319	0.00147	CcSEcCtD
Fluorescein—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000319	0.00147	CcSEcCtD
Fluorescein—Dizziness—Raloxifene—osteoporosis	0.000319	0.00147	CcSEcCtD
Fluorescein—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000318	0.00146	CcSEcCtD
Fluorescein—Vomiting—Estropipate—osteoporosis	0.000317	0.00146	CcSEcCtD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000316	0.0138	CbGpPWpGaD
Fluorescein—Dysgeusia—Estradiol—osteoporosis	0.000316	0.00145	CcSEcCtD
Fluorescein—Dizziness—Ibandronate—osteoporosis	0.000316	0.00145	CcSEcCtD
Fluorescein—Rash—Estropipate—osteoporosis	0.000314	0.00144	CcSEcCtD
Fluorescein—Dermatitis—Estropipate—osteoporosis	0.000314	0.00144	CcSEcCtD
Fluorescein—Urticaria—Risedronate—osteoporosis	0.000313	0.00144	CcSEcCtD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000312	0.0136	CbGpPWpGaD
Fluorescein—Headache—Estropipate—osteoporosis	0.000312	0.00143	CcSEcCtD
Fluorescein—Vomiting—Alendronate—osteoporosis	0.000312	0.00143	CcSEcCtD
Fluorescein—Abdominal pain—Risedronate—osteoporosis	0.000311	0.00143	CcSEcCtD
Fluorescein—Rash—Alendronate—osteoporosis	0.000309	0.00142	CcSEcCtD
Fluorescein—Dermatitis—Alendronate—osteoporosis	0.000309	0.00142	CcSEcCtD
Fluorescein—Feeling abnormal—Pamidronate—osteoporosis	0.000308	0.00142	CcSEcCtD
Fluorescein—Hypotension—Conjugated Estrogens—osteoporosis	0.000308	0.00141	CcSEcCtD
Fluorescein—Headache—Alendronate—osteoporosis	0.000307	0.00141	CcSEcCtD
Fluorescein—Paraesthesia—Zoledronate—osteoporosis	0.000307	0.00141	CcSEcCtD
Fluorescein—Vomiting—Raloxifene—osteoporosis	0.000307	0.00141	CcSEcCtD
Fluorescein—Gastrointestinal pain—Pamidronate—osteoporosis	0.000306	0.00141	CcSEcCtD
Fluorescein—Dyspnoea—Zoledronate—osteoporosis	0.000305	0.0014	CcSEcCtD
Fluorescein—Rash—Raloxifene—osteoporosis	0.000304	0.0014	CcSEcCtD
Fluorescein—Dermatitis—Raloxifene—osteoporosis	0.000304	0.0014	CcSEcCtD
Fluorescein—Vomiting—Ibandronate—osteoporosis	0.000304	0.0014	CcSEcCtD
Fluorescein—Tremor—Estradiol—osteoporosis	0.000302	0.00139	CcSEcCtD
Fluorescein—Headache—Raloxifene—osteoporosis	0.000302	0.00139	CcSEcCtD
Fluorescein—Rash—Ibandronate—osteoporosis	0.000301	0.00138	CcSEcCtD
Fluorescein—Dermatitis—Ibandronate—osteoporosis	0.000301	0.00138	CcSEcCtD
Fluorescein—Ill-defined disorder—Estradiol—osteoporosis	0.000299	0.00138	CcSEcCtD
Fluorescein—Headache—Ibandronate—osteoporosis	0.000299	0.00137	CcSEcCtD
Fluorescein—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000297	0.00137	CcSEcCtD
Fluorescein—Vomiting—Calcitriol—osteoporosis	0.000297	0.00137	CcSEcCtD
Fluorescein—Nausea—Estropipate—osteoporosis	0.000296	0.00136	CcSEcCtD
Fluorescein—Abdominal pain—Pamidronate—osteoporosis	0.000296	0.00136	CcSEcCtD
Fluorescein—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000296	0.00136	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000295	0.00136	CcSEcCtD
Fluorescein—Rash—Calcitriol—osteoporosis	0.000295	0.00135	CcSEcCtD
Fluorescein—Dermatitis—Calcitriol—osteoporosis	0.000295	0.00135	CcSEcCtD
Fluorescein—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000293	0.00135	CcSEcCtD
Fluorescein—Headache—Calcitriol—osteoporosis	0.000293	0.00135	CcSEcCtD
Fluorescein—Pain—Zoledronate—osteoporosis	0.000292	0.00134	CcSEcCtD
Fluorescein—Nausea—Alendronate—osteoporosis	0.000291	0.00134	CcSEcCtD
Fluorescein—Malaise—Estradiol—osteoporosis	0.000291	0.00134	CcSEcCtD
Fluorescein—Hypersensitivity—Risedronate—osteoporosis	0.00029	0.00133	CcSEcCtD
Fluorescein—Asthenia—Ethinyl Estradiol—osteoporosis	0.00029	0.00133	CcSEcCtD
Fluorescein—Syncope—Estradiol—osteoporosis	0.000289	0.00133	CcSEcCtD
Fluorescein—Nausea—Raloxifene—osteoporosis	0.000287	0.00132	CcSEcCtD
Fluorescein—Pruritus—Ethinyl Estradiol—osteoporosis	0.000286	0.00131	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000284	0.00131	CcSEcCtD
Fluorescein—Nausea—Ibandronate—osteoporosis	0.000284	0.0013	CcSEcCtD
Fluorescein—Loss of consciousness—Estradiol—osteoporosis	0.000284	0.0013	CcSEcCtD
Fluorescein—Asthenia—Risedronate—osteoporosis	0.000282	0.0013	CcSEcCtD
Fluorescein—Feeling abnormal—Zoledronate—osteoporosis	0.000282	0.00129	CcSEcCtD
Fluorescein—Cough—Estradiol—osteoporosis	0.000282	0.00129	CcSEcCtD
Fluorescein—Pain—Conjugated Estrogens—osteoporosis	0.000281	0.00129	CcSEcCtD
Fluorescein—Gastrointestinal pain—Zoledronate—osteoporosis	0.000279	0.00128	CcSEcCtD
Fluorescein—Hypertension—Estradiol—osteoporosis	0.000279	0.00128	CcSEcCtD
Fluorescein—Pruritus—Risedronate—osteoporosis	0.000278	0.00128	CcSEcCtD
Fluorescein—Nausea—Calcitriol—osteoporosis	0.000278	0.00128	CcSEcCtD
Fluorescein—Hypersensitivity—Pamidronate—osteoporosis	0.000276	0.00127	CcSEcCtD
Fluorescein—Chest pain—Estradiol—osteoporosis	0.000275	0.00126	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000273	0.00125	CcSEcCtD
Fluorescein—Urticaria—Zoledronate—osteoporosis	0.000272	0.00125	CcSEcCtD
Fluorescein—Discomfort—Estradiol—osteoporosis	0.000271	0.00125	CcSEcCtD
Fluorescein—Abdominal pain—Zoledronate—osteoporosis	0.00027	0.00124	CcSEcCtD
Fluorescein—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000269	0.00124	CcSEcCtD
Fluorescein—Asthenia—Pamidronate—osteoporosis	0.000268	0.00123	CcSEcCtD
Fluorescein—Dizziness—Ethinyl Estradiol—osteoporosis	0.000267	0.00123	CcSEcCtD
Fluorescein—Pruritus—Pamidronate—osteoporosis	0.000265	0.00122	CcSEcCtD
Fluorescein—Oedema—Estradiol—osteoporosis	0.000263	0.00121	CcSEcCtD
Fluorescein—Anaphylactic shock—Estradiol—osteoporosis	0.000263	0.00121	CcSEcCtD
Fluorescein—ABCC1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000263	0.0115	CbGpPWpGaD
Fluorescein—Urticaria—Conjugated Estrogens—osteoporosis	0.000261	0.0012	CcSEcCtD
Fluorescein—Dizziness—Risedronate—osteoporosis	0.00026	0.0012	CcSEcCtD
Fluorescein—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00026	0.0012	CcSEcCtD
Fluorescein—Shock—Estradiol—osteoporosis	0.000259	0.00119	CcSEcCtD
Fluorescein—Nervous system disorder—Estradiol—osteoporosis	0.000258	0.00119	CcSEcCtD
Fluorescein—Tachycardia—Estradiol—osteoporosis	0.000257	0.00118	CcSEcCtD
Fluorescein—Vomiting—Ethinyl Estradiol—osteoporosis	0.000257	0.00118	CcSEcCtD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000257	0.0112	CbGpPWpGaD
Fluorescein—Skin disorder—Estradiol—osteoporosis	0.000256	0.00118	CcSEcCtD
Fluorescein—Hyperhidrosis—Estradiol—osteoporosis	0.000255	0.00117	CcSEcCtD
Fluorescein—Rash—Ethinyl Estradiol—osteoporosis	0.000255	0.00117	CcSEcCtD
Fluorescein—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000254	0.00117	CcSEcCtD
Fluorescein—Headache—Ethinyl Estradiol—osteoporosis	0.000253	0.00116	CcSEcCtD
Fluorescein—Hypersensitivity—Zoledronate—osteoporosis	0.000252	0.00116	CcSEcCtD
Fluorescein—Vomiting—Risedronate—osteoporosis	0.00025	0.00115	CcSEcCtD
Fluorescein—Rash—Risedronate—osteoporosis	0.000248	0.00114	CcSEcCtD
Fluorescein—Dermatitis—Risedronate—osteoporosis	0.000248	0.00114	CcSEcCtD
Fluorescein—Dizziness—Pamidronate—osteoporosis	0.000247	0.00114	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—SOD2—osteoporosis	0.000247	0.0108	CbGpPWpGaD
Fluorescein—Headache—Risedronate—osteoporosis	0.000247	0.00113	CcSEcCtD
Fluorescein—Asthenia—Zoledronate—osteoporosis	0.000245	0.00113	CcSEcCtD
Fluorescein—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000242	0.00111	CcSEcCtD
Fluorescein—Pruritus—Zoledronate—osteoporosis	0.000242	0.00111	CcSEcCtD
Fluorescein—Nausea—Ethinyl Estradiol—osteoporosis	0.00024	0.0011	CcSEcCtD
Fluorescein—Vomiting—Pamidronate—osteoporosis	0.000238	0.00109	CcSEcCtD
Fluorescein—Paraesthesia—Estradiol—osteoporosis	0.000237	0.00109	CcSEcCtD
Fluorescein—Asthenia—Conjugated Estrogens—osteoporosis	0.000236	0.00108	CcSEcCtD
Fluorescein—Rash—Pamidronate—osteoporosis	0.000236	0.00108	CcSEcCtD
Fluorescein—Dermatitis—Pamidronate—osteoporosis	0.000236	0.00108	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—GPX1—osteoporosis	0.000236	0.0103	CbGpPWpGaD
Fluorescein—Dyspnoea—Estradiol—osteoporosis	0.000235	0.00108	CcSEcCtD
Fluorescein—Headache—Pamidronate—osteoporosis	0.000234	0.00108	CcSEcCtD
Fluorescein—Nausea—Risedronate—osteoporosis	0.000234	0.00107	CcSEcCtD
Fluorescein—Pruritus—Conjugated Estrogens—osteoporosis	0.000233	0.00107	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Estradiol—osteoporosis	0.000227	0.00104	CcSEcCtD
Fluorescein—Dizziness—Zoledronate—osteoporosis	0.000226	0.00104	CcSEcCtD
Fluorescein—Pain—Estradiol—osteoporosis	0.000225	0.00103	CcSEcCtD
Fluorescein—Nausea—Pamidronate—osteoporosis	0.000222	0.00102	CcSEcCtD
Fluorescein—Dizziness—Conjugated Estrogens—osteoporosis	0.000218	0.001	CcSEcCtD
Fluorescein—Vomiting—Zoledronate—osteoporosis	0.000217	0.000999	CcSEcCtD
Fluorescein—Feeling abnormal—Estradiol—osteoporosis	0.000217	0.000997	CcSEcCtD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.000217	0.00945	CbGpPWpGaD
Fluorescein—Rash—Zoledronate—osteoporosis	0.000215	0.00099	CcSEcCtD
Fluorescein—Gastrointestinal pain—Estradiol—osteoporosis	0.000215	0.00099	CcSEcCtD
Fluorescein—Dermatitis—Zoledronate—osteoporosis	0.000215	0.000989	CcSEcCtD
Fluorescein—Headache—Zoledronate—osteoporosis	0.000214	0.000984	CcSEcCtD
Fluorescein—Vomiting—Conjugated Estrogens—osteoporosis	0.000209	0.000962	CcSEcCtD
Fluorescein—Urticaria—Estradiol—osteoporosis	0.000209	0.000961	CcSEcCtD
Fluorescein—Abdominal pain—Estradiol—osteoporosis	0.000208	0.000957	CcSEcCtD
Fluorescein—Rash—Conjugated Estrogens—osteoporosis	0.000207	0.000953	CcSEcCtD
Fluorescein—Dermatitis—Conjugated Estrogens—osteoporosis	0.000207	0.000953	CcSEcCtD
Fluorescein—Headache—Conjugated Estrogens—osteoporosis	0.000206	0.000947	CcSEcCtD
Fluorescein—CYP1A1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000206	0.00896	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000204	0.00888	CbGpPWpGaD
Fluorescein—Nausea—Zoledronate—osteoporosis	0.000203	0.000933	CcSEcCtD
Fluorescein—Nausea—Conjugated Estrogens—osteoporosis	0.000195	0.000898	CcSEcCtD
Fluorescein—Hypersensitivity—Estradiol—osteoporosis	0.000194	0.000892	CcSEcCtD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000193	0.00841	CbGpPWpGaD
Fluorescein—Asthenia—Estradiol—osteoporosis	0.000189	0.000868	CcSEcCtD
Fluorescein—Pruritus—Estradiol—osteoporosis	0.000186	0.000856	CcSEcCtD
Fluorescein—Dizziness—Estradiol—osteoporosis	0.000174	0.0008	CcSEcCtD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000169	0.00735	CbGpPWpGaD
Fluorescein—Vomiting—Estradiol—osteoporosis	0.000167	0.00077	CcSEcCtD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000166	0.00725	CbGpPWpGaD
Fluorescein—Rash—Estradiol—osteoporosis	0.000166	0.000763	CcSEcCtD
Fluorescein—Dermatitis—Estradiol—osteoporosis	0.000166	0.000762	CcSEcCtD
Fluorescein—Headache—Estradiol—osteoporosis	0.000165	0.000758	CcSEcCtD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000164	0.00715	CbGpPWpGaD
Fluorescein—CYP1A1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000157	0.00683	CbGpPWpGaD
Fluorescein—Nausea—Estradiol—osteoporosis	0.000156	0.000719	CcSEcCtD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000156	0.00679	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000153	0.00667	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00015	0.00654	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000146	0.00638	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000145	0.00632	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000137	0.00599	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	0.000136	0.00594	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000135	0.00587	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000134	0.00586	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000117	0.0051	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000113	0.00492	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00011	0.00479	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.99e-05	0.00435	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.98e-05	0.00435	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.94e-05	0.00433	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.56e-05	0.00417	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	9.17e-05	0.004	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.11e-05	0.00397	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PKM—osteoporosis	9.07e-05	0.00395	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—FDPS—osteoporosis	9.07e-05	0.00395	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.79e-05	0.00383	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.64e-05	0.00376	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PGLS—osteoporosis	8.6e-05	0.00375	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GPD2—osteoporosis	8.6e-05	0.00375	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PKM—osteoporosis	8.14e-05	0.00355	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SOST—osteoporosis	8.14e-05	0.00355	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.1e-05	0.00353	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ATIC—osteoporosis	7.86e-05	0.00343	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PNP—osteoporosis	7.86e-05	0.00343	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PGLS—osteoporosis	7.71e-05	0.00336	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ANTXR2—osteoporosis	7.71e-05	0.00336	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.47e-05	0.00326	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	7.16e-05	0.00312	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	7.14e-05	0.00311	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	7.13e-05	0.00311	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	7.06e-05	0.00308	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—FDPS—osteoporosis	6.81e-05	0.00297	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PKM—osteoporosis	6.81e-05	0.00297	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.72e-05	0.00293	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—OXCT1—osteoporosis	6.69e-05	0.00291	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CA2—osteoporosis	6.69e-05	0.00291	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	6.65e-05	0.0029	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	6.65e-05	0.0029	CbGpPWpGaD
Fluorescein—ABCC1—Disease—GSN—osteoporosis	6.56e-05	0.00286	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.55e-05	0.00285	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MGLL—osteoporosis	6.52e-05	0.00284	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GPD2—osteoporosis	6.46e-05	0.00281	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PGLS—osteoporosis	6.46e-05	0.00281	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.14e-05	0.00268	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ATIC—osteoporosis	5.91e-05	0.00257	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PNP—osteoporosis	5.91e-05	0.00257	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LRP5—osteoporosis	5.7e-05	0.00249	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—IDH2—osteoporosis	5.54e-05	0.00241	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LRP6—osteoporosis	5.46e-05	0.00238	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LTF—osteoporosis	5.24e-05	0.00228	CbGpPWpGaD
Fluorescein—ABCC1—Disease—RPL24—osteoporosis	5.24e-05	0.00228	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.23e-05	0.00228	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP27A1—osteoporosis	5.21e-05	0.00227	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ACP5—osteoporosis	5.07e-05	0.00221	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—OXCT1—osteoporosis	5.02e-05	0.00219	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CA2—osteoporosis	5.02e-05	0.00219	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5e-05	0.00218	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MGLL—osteoporosis	4.89e-05	0.00213	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—TPI1—osteoporosis	4.71e-05	0.00205	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.62e-05	0.00201	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ACP5—osteoporosis	4.55e-05	0.00198	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.45e-05	0.00194	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—P4HB—osteoporosis	4.43e-05	0.00193	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GAPDH—osteoporosis	4.35e-05	0.00189	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—POMC—osteoporosis	4.3e-05	0.00188	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—RAP1A—osteoporosis	4.23e-05	0.00185	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TPI1—osteoporosis	4.23e-05	0.00184	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—IDH2—osteoporosis	4.16e-05	0.00181	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—FDPS—osteoporosis	4.06e-05	0.00177	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PKM—osteoporosis	4.06e-05	0.00177	CbGpPWpGaD
Fluorescein—ABCC1—Disease—P4HB—osteoporosis	3.97e-05	0.00173	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP27A1—osteoporosis	3.91e-05	0.00171	CbGpPWpGaD
Fluorescein—ABCC1—Disease—GAPDH—osteoporosis	3.9e-05	0.0017	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PGLS—osteoporosis	3.85e-05	0.00168	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GPD2—osteoporosis	3.85e-05	0.00168	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ACP5—osteoporosis	3.81e-05	0.00166	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.76e-05	0.00164	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.75e-05	0.00163	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NFATC1—osteoporosis	3.71e-05	0.00161	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.69e-05	0.00161	CbGpPWpGaD
Fluorescein—ABCC1—Disease—DKK1—osteoporosis	3.68e-05	0.0016	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.59e-05	0.00156	CbGpPWpGaD
Fluorescein—ABCC1—Disease—WNT1—osteoporosis	3.54e-05	0.00154	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TPI1—osteoporosis	3.54e-05	0.00154	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ATIC—osteoporosis	3.52e-05	0.00153	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PNP—osteoporosis	3.52e-05	0.00153	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGA—osteoporosis	3.44e-05	0.0015	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ENO1—osteoporosis	3.42e-05	0.00149	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PSMA5—osteoporosis	3.37e-05	0.00147	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PSMA2—osteoporosis	3.37e-05	0.00147	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—P4HB—osteoporosis	3.33e-05	0.00145	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GAPDH—osteoporosis	3.27e-05	0.00142	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—RAP1A—osteoporosis	3.18e-05	0.00139	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ENO1—osteoporosis	3.07e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PSMA2—osteoporosis	3.03e-05	0.00132	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PSMA5—osteoporosis	3.03e-05	0.00132	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—OXCT1—osteoporosis	2.99e-05	0.0013	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CA2—osteoporosis	2.99e-05	0.0013	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MGLL—osteoporosis	2.92e-05	0.00127	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CALCA—osteoporosis	2.82e-05	0.00123	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-05	0.00121	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.75e-05	0.0012	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP19A1—osteoporosis	2.74e-05	0.00119	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ENO1—osteoporosis	2.57e-05	0.00112	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KL—osteoporosis	2.56e-05	0.00112	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PSMA2—osteoporosis	2.53e-05	0.0011	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PSMA5—osteoporosis	2.53e-05	0.0011	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—IDH2—osteoporosis	2.48e-05	0.00108	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.00102	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ACP5—osteoporosis	2.27e-05	0.000988	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.24e-05	0.000976	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ADCY5—osteoporosis	2.24e-05	0.000974	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GPX1—osteoporosis	2.23e-05	0.000971	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TPI1—osteoporosis	2.11e-05	0.000919	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MTHFR—osteoporosis	2.06e-05	0.000896	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP19A1—osteoporosis	2.06e-05	0.000896	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ADCY5—osteoporosis	2.01e-05	0.000874	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—P4HB—osteoporosis	1.98e-05	0.000864	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GAPDH—osteoporosis	1.95e-05	0.000848	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—RAP1A—osteoporosis	1.89e-05	0.000826	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MTHFR—osteoporosis	1.84e-05	0.000804	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IRS2—osteoporosis	1.75e-05	0.000765	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000732	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GPX1—osteoporosis	1.67e-05	0.000729	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.65e-05	0.00072	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—POMC—osteoporosis	1.64e-05	0.000717	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MTHFR—osteoporosis	1.54e-05	0.000673	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IRS1—osteoporosis	1.53e-05	0.000668	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ENO1—osteoporosis	1.53e-05	0.000667	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000658	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000658	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6R—osteoporosis	1.44e-05	0.000627	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—POMC—osteoporosis	1.24e-05	0.000538	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000534	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ADCY5—osteoporosis	1e-05	0.000436	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GPX1—osteoporosis	9.97e-06	0.000434	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTHFR—osteoporosis	9.2e-06	0.000401	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MYC—osteoporosis	8.53e-06	0.000372	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFB1—osteoporosis	8.51e-06	0.000371	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—POMC—osteoporosis	7.36e-06	0.000321	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6—osteoporosis	6.41e-06	0.000279	CbGpPWpGaD
